New hope for kids with severe bowel disease
NCT ID NCT07158242
Summary
This study is testing whether a new medication called afimkibart can help children aged 2-17 who have moderate to severe ulcerative colitis, a painful bowel disease. Researchers want to see if the treatment can bring the disease under control and keep it controlled for a year. The trial is for children who haven't gotten enough relief from standard treatments like steroids or other biologic drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrooke's Hospital
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Children's Healthcare of Atlanta
RECRUITINGAtlanta, Georgia, 30342, United States
-
NYU School of Medicine
RECRUITINGNew York, New York, 10016, United States
-
National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
Conditions
Explore the condition pages connected to this study.